EGFR exon 20 insertion mutations in Chinese advanced non-small cell lung cancer patients: Molecular heterogeneity and treatment outcome from nationwide real-world study

Lung Cancer ◽

10.1016/j.lungcan.2020.03.014 ◽

2020 ◽

Vol 145 ◽

pp. 186-194 ◽

Author(s):

Guangjian Yang ◽

Jun Li ◽

Haiyan Xu ◽

Yaning Yang ◽

Lu Yang ◽

...

Keyword(s):

Lung Cancer ◽

Treatment Outcome ◽

Cancer Patients ◽

Molecular Heterogeneity ◽

Small Cell Lung ◽

Lung Cancer Patients ◽

Exon 20 ◽

Insertion Mutations

Download Full-text

P2.01-103 Real-World Treatment Patterns and Survival in Non-Small Cell Lung Cancer Patients with EGFR Exon 20 Insertion Mutations

Journal of Thoracic Oncology ◽

10.1016/j.jtho.2019.08.1446 ◽

2019 ◽

Vol 14 (10) ◽

pp. S681

Author(s):

M. Dersarkissian ◽

R. Bhak ◽

H. Lin ◽

S. Li ◽

M. Cheng ◽

...

Keyword(s):

Lung Cancer ◽

Small Cell Lung Cancer ◽

Cancer Patients ◽

Treatment Patterns ◽

Small Cell Lung ◽

Lung Cancer Patients ◽

Exon 20 ◽

Insertion Mutations

Download Full-text

Osimertinib for Chinese advanced non-small cell lung cancer patients harboring diverse EGFR exon 20 insertion mutations

Lung Cancer ◽

10.1016/j.lungcan.2020.11.027 ◽

2021 ◽

Vol 152 ◽

pp. 39-48

Author(s):

Guang-Jian Yang ◽

Jun Li ◽

Hai-Yan Xu ◽

Yang Sun ◽

Liu Liu ◽

...

Keyword(s):

Lung Cancer ◽

Small Cell Lung Cancer ◽

Cancer Patients ◽

Cell Lung Cancer ◽

Small Cell Lung ◽

Lung Cancer Patients ◽

Exon 20 ◽

Insertion Mutations

Download Full-text

Abstract CT106: Phase I/II study of osimertinib in EGFR exon 20 insertion mutations in non-small cell lung cancer patients: AEX20

10.1158/1538-7445.am2021-ct106 ◽

2021 ◽

Author(s):

Eiki Ichihara ◽

Hiroyuki Yasuda ◽

Yuta Takashima ◽

Yoshitaka Zenke ◽

Shinji Takeuchi ◽

...

Keyword(s):

Lung Cancer ◽

Phase I ◽

Small Cell Lung Cancer ◽

Cancer Patients ◽

Cell Lung Cancer ◽

Small Cell Lung ◽

Lung Cancer Patients ◽

Exon 20 ◽

Insertion Mutations

Download Full-text

Real‐World Utilization of EGFR TKIs and Prognostic Factors for Survival in EGFR‐Mutated Non‐Small Cell Lung Cancer Patients with Brain Metastases

International Journal of Cancer ◽

10.1002/ijc.33677 ◽

2021 ◽

Author(s):

Xiaoqing Yu ◽

Jiamin Sheng ◽

Guoqiang Pan ◽

Yun Fan

Keyword(s):

Lung Cancer ◽

Prognostic Factors ◽

Brain Metastases ◽

Cancer Patients ◽

Small Cell Lung ◽

Lung Cancer Patients ◽

Egfr Mutated ◽

Download Full-text

Pyrotinib in HER2 Heterogeneously Mutated or Amplified Advanced Non-small Cell Lung Cancer Patients: A Retrospective Real-world Study (PEARL)

Journal of the National Cancer Center ◽

10.1016/j.jncc.2021.08.001 ◽

2021 ◽

Author(s):

Guangjian Yang ◽

Xuezhi Hao ◽

Jiaqi Hu ◽

Keke Dong ◽

Haiyan Xu ◽

...

Keyword(s):

Lung Cancer ◽

Small Cell Lung Cancer ◽

Cancer Patients ◽

Cell Lung Cancer ◽

Small Cell Lung ◽

Lung Cancer Patients

Download Full-text

Impact of ERCC1 expression on treatment outcome in small-cell lung cancer patients treated with platinum-based chemotherapy

European Journal of Cancer ◽

10.1016/j.ejca.2012.06.011 ◽

2012 ◽

Vol 48 (18) ◽

pp. 3378-3385 ◽

Author(s):

Eva Sodja ◽

Lea Knez ◽

Izidor Kern ◽

Tanja Ovčariček ◽

Aleksander Sadikov ◽

...

Keyword(s):

Lung Cancer ◽

Treatment Outcome ◽

Small Cell Lung Cancer ◽

Cancer Patients ◽

Cell Lung Cancer ◽

Small Cell Lung ◽

Lung Cancer Patients ◽

Platinum Based Chemotherapy ◽

Ercc1 Expression

Download Full-text

Abstract 1616: Characterizing differences in checkpoint inhibitor biomarkers in a real-world cohort of stage III and IV non-small cell lung cancer patients

10.1158/1538-7445.am2021-1616 ◽

2021 ◽

Author(s):

Yinjie Gao ◽

Michelle M. Stein ◽

Prerna Jain ◽

Denise Lau ◽

Kimberly L. Blackwell ◽

...

Keyword(s):

Lung Cancer ◽

Small Cell Lung Cancer ◽

Cancer Patients ◽

Cell Lung Cancer ◽

Checkpoint Inhibitor ◽

Stage Iii ◽

Small Cell Lung ◽

Lung Cancer Patients

Download Full-text

Tumor PD-L1 Expression and Clinical Outcomes in Advanced-stage Non-Small Cell Lung Cancer Patients Treated with Nivolumab or Pembrolizumab: Real-World Data in Taiwan

Journal of Cancer ◽

10.7150/jca.24985 ◽

2018 ◽

Vol 9 (10) ◽

pp. 1813-1820 ◽

Author(s):

Shu-Yung Lin ◽

Ching-Yao Yang ◽

Bin-Chi Liao ◽

Chao-Chi Ho ◽

Wei-Yu Liao ◽

...

Keyword(s):

Lung Cancer ◽

Small Cell Lung Cancer ◽

Cancer Patients ◽

Clinical Outcomes ◽

Advanced Stage ◽

Small Cell Lung ◽

Real World Data ◽

Lung Cancer Patients

Download Full-text

Real-world outcomes of chemo-antiangiogenesis versus chemo-immunotherapy combinations in EGFR-mutant advanced non-small cell lung cancer patients after failure of EGFR-TKI therapy

Translational Lung Cancer Research ◽

10.21037/tlcr-21-681 ◽

2021 ◽

Vol 10 (9) ◽

pp. 3782-3792

Author(s):

Xin Yu ◽

Jiaqi Li ◽

Lingyun Ye ◽

Jing Zhao ◽

Mengqing Xie ◽

...

Keyword(s):

Lung Cancer ◽

Small Cell Lung Cancer ◽

Cancer Patients ◽

Cell Lung Cancer ◽

Small Cell Lung ◽

Lung Cancer Patients ◽

Egfr Mutant ◽

Download Full-text

FP10.01 The Efficacy of Immunotherapy in non-Small Cell Lung Cancer Patients with Uncommon Mutations: a Real World Research from Single Site

Journal of Thoracic Oncology ◽

10.1016/j.jtho.2021.08.239 ◽

2021 ◽

Vol 16 (10) ◽

pp. S962

Author(s):

Y. Cheng ◽

Y. Zhang ◽

Y. Liu ◽

X. Liu ◽

C. Zhang ◽

...

Keyword(s):

Lung Cancer ◽

Small Cell Lung Cancer ◽

Cancer Patients ◽

Cell Lung Cancer ◽

Single Site ◽

Small Cell Lung ◽

Lung Cancer Patients

Download Full-text